Related Experiment Videos
Clinical experience with the isotopic cardiac pacemaker
Insights
Isotopic pacemakers showed no failures over 5.5 years, unlike conventional ones. These nuclear-powered devices may offer longer, potentially lifelong cardiac pacing, with minimal cancer risk, especially for older patients.
Area of Science:
- Cardiology
- Biomedical Engineering
- Nuclear Medicine
Background:
- Conventional pacemakers utilize chemical batteries, which have a finite lifespan and are prone to failure.
- Isotopic pacemakers, powered by radioisotope thermoelectric generators, offer a potentially longer-lasting alternative.
- Evaluating the long-term performance and safety of isotopic cardiac pacing is crucial.
Purpose of the Study:
- To compare the clinical performance of isotopic pacemakers with conventional chemical battery-powered pulse generators.
- To assess the longevity and reliability of isotopic cardiac pacing over a 5.5-year period.
- To evaluate the safety profile, including carcinogenesis risk, of isotopic pacemakers.
Main Methods:
- A retrospective clinical comparison of 59 patients with isotopic pacemakers and 77 control patients with conventional pacemakers.
- Data collection covered a 5.5-year period, examining device performance and patient outcomes.
- Statistical analysis was limited due to numerous confounding variables between the groups.
Main Results:
- No pulse generator failures were observed in the isotopic pacemaker group.
- Pulse generator failures occurred in the control group with conventional devices.
- The isotopic cardiac pacer is suggested to have a longer lifespan than conventional units.
- Carcinogenesis risk associated with isotopic pacemakers is considered minimal, particularly in older individuals.
Conclusions:
- Isotopic cardiac pacemakers demonstrate promising reliability and longevity, potentially offering lifelong pacing.
- The safety profile, including negligible carcinogenesis risk in older patients, supports their consideration.
- Isotopic pacemakers may be particularly indicated for patients with a life expectancy of 10 years or more, including older individuals.
Abstract:
Clinical experience with isotopic pacemakers in 59 patients is compared with that in 77 control patients having conventional chemical battery-powered pulse generators. The review covers a 51/2-year period. Statistical analysis of the two series is impossible because of the numerous variables such as age, type of disease, number of controls, types of test and control pulse generators, dates of insertion, and protocol regulations. However, there were pulse generator failures in the control group, but not in the test group. Though not proven in this study, the isotopic cardiac pacer is likely to last longer than conventional chemical battery-powered units, and could provide lifetime pacing for many patients. The risk of carcinogenesis is minimal and seems negligible in older patients. The isotopic cardiac pacer, in spite of restrictions of the Nuclear Regulatory Commission, should be considered for any patient with a life expectancy of 10 or more years. Paradoxically, it might be indicated in older rather than younger patients.